Naz Rajesh K
Reproductive Immunology and Molecular Biology Laboratories, Department of Obstetrics and Gynecology, The West Virginia University, School of Medicine, Morgantown, WV 26505-9186, USA.
Mol Reprod Dev. 2008 Feb;75(2):336-44. doi: 10.1002/mrd.20783.
Sperm proteins are being investigated for their applications in the development of contraceptive vaccines (CV) in several laboratories. In the present study, various synthetic peptides based upon four sperm proteins, namely Izumo, fertilization antigen-1 (FA-1), YLP(12), and SP56 that are involved in various steps of the fertilization cascade were examined for their immunocontraceptive effect. The synthetic peptides were conjugated to four carrier proteins namely keyhole limpet hemocyanin (KLH), bovine serum albumin (BSA), chicken gamma-globulin, and chicken ovalbumin. Female mice were immunized with various peptide vaccines and each booster injection was given with the peptide conjugated to a different carrier protein. Two different fertility trials with different doses of the peptide vaccines were conducted to examine the contraceptive effect. Injection of 150 microg of the peptides (Trial II) caused a significantly higher immune response in serum as well as in the vaginal tract causing enhanced contraceptive effect than those observed after injection with 75 microg of the peptides (Trial I). Immunization with the peptide vaccines based upon Izumo, which is involved in sperm-egg plasma membrane fusion, caused a significant reduction in fertility. The contraceptive effect was enhanced by immunizing with the peptides based upon other antigens (FA-1, YLP(12), and SP56), resulting in an overall 73.33% reduction in fertility. When the antibodies against the peptides disappeared after >9-10 months from circulation and genital tract, all the animals regained fertility. These findings indicate for the first time that the immunization with Izumo and other sperm peptides namely FA-1, YLP(12), and SP56 induces antibodies in serum and genital tract that cause a reversible long-term contraceptive effect in female mice. The data further indicate that the proteins involved in sperm-egg fusion can also be used for contraceptive vaccine development. The contraceptive effects are enhanced by immunizing with the multipeptide vaccines.
多个实验室正在研究精子蛋白在避孕疫苗(CV)研发中的应用。在本研究中,对基于四种参与受精级联反应不同步骤的精子蛋白(即 Izumo、受精抗原 -1(FA-1)、YLP(12) 和 SP56)的各种合成肽进行了免疫避孕效果检测。这些合成肽与四种载体蛋白偶联,即匙孔血蓝蛋白(KLH)、牛血清白蛋白(BSA)、鸡γ球蛋白和鸡卵白蛋白。用各种肽疫苗对雌性小鼠进行免疫,每次加强注射时使用与不同载体蛋白偶联的肽。进行了两次不同剂量肽疫苗的生育力试验以检测避孕效果。注射 150 微克肽(试验 II)在血清和阴道中引起的免疫反应明显高于注射 75 微克肽(试验 I),导致避孕效果增强。基于参与精卵质膜融合的 Izumo 的肽疫苗免疫导致生育力显著降低。基于其他抗原(FA-1、YLP(12) 和 SP56)的肽免疫增强了避孕效果,使总体生育力降低了 73.33%。当循环和生殖道中针对这些肽的抗体在 9 - 10 个月后消失时,所有动物都恢复了生育能力。这些发现首次表明,用 Izumo 和其他精子肽(即 FA-1、YLP(12) 和 SP56)免疫可在血清和生殖道中诱导抗体,从而在雌性小鼠中产生可逆的长期避孕效果。数据还表明,参与精卵融合的蛋白质也可用于避孕疫苗的研发。多种肽疫苗免疫可增强避孕效果。